Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinagolide in Oocyte Donors at Risk of OHSS
NCT00665041Phase 2Completed
- Sponsor
- IVI
- Start
- May 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quinagolide in ovarian hyperstimulation syndrome (OHSS), sponsored by IVI. Started May 2008; status: completed.
02
Drugs
quinagolide
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT00665041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00665041.